Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the ...
SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...
Morning Overview on MSN
Photonics and nanotech may detect cancer signals 5 to 8 years early
Scientists working at the intersection of photonics and nanotechnology are building tools that could identify cancer-related signals in blood samples collected five to eight years before a clinical ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients. The cobas EGFR Mutation Test v2 is a ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.
NEW YORK, NY, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- Liv Hospital today launched an informative guide to ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results